These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 23421452)
1. Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report. Cage TA; Pekmezci M; Prados M; Berger MS J Neurosurg; 2013 Jun; 118(6):1220-3. PubMed ID: 23421452 [TBL] [Abstract][Full Text] [Related]
2. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781 [TBL] [Abstract][Full Text] [Related]
4. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704 [TBL] [Abstract][Full Text] [Related]
5. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy. Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719 [TBL] [Abstract][Full Text] [Related]
6. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival. Coburger J; Hagel V; Wirtz CR; König R PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409 [TBL] [Abstract][Full Text] [Related]
7. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387 [TBL] [Abstract][Full Text] [Related]
8. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas. Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783 [TBL] [Abstract][Full Text] [Related]
9. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075 [TBL] [Abstract][Full Text] [Related]
10. 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature. Barbagallo GM; Certo F; Heiss K; Albanese V Br J Neurosurg; 2014 Dec; 28(6):750-4. PubMed ID: 24799277 [TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas. Chohan MO; Berger MS J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ J Neurosurg; 2000 Dec; 93(6):1003-13. PubMed ID: 11117842 [TBL] [Abstract][Full Text] [Related]
13. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402 [TBL] [Abstract][Full Text] [Related]
14. Periventricular glioblastomas and ependymal involvement interrogated using intraoperative fluorescence - a pathological correlative study. Moiyadi AV; Shetty P; Sridhar E Br J Neurosurg; 2017 Feb; 31(1):107-112. PubMed ID: 27648634 [TBL] [Abstract][Full Text] [Related]
15. Is it a glioblastoma? In dubio pro 5-ALA! Kamp MA; Santacroce A; Zella S; Reichelt DC; Felsberg J; Steiger HJ; Cornelius JF; Sabel M Acta Neurochir (Wien); 2012 Jul; 154(7):1269-73. PubMed ID: 22576268 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence-guided resection with 5-aminolevulinic Acid of subependymomas of the fourth ventricle: report of 2 cases: technical case report. Bernal García LM; Cabezudo Artero JM; Marcelo Zamorano MB; Gilete Tejero I Neurosurgery; 2015 Jun; 11 Suppl 2():E364-71; discussion E371. PubMed ID: 25950889 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence-guided operation in recurrent glioblastoma multiforme treated with bevacizumab-fluorescence of the noncontrast enhancing tumor tissue? Wachter D; Kallenberg K; Wrede A; Schulz-Schaeffer W; Behm T; Rohde V J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):401-6. PubMed ID: 22777926 [TBL] [Abstract][Full Text] [Related]
18. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888 [TBL] [Abstract][Full Text] [Related]
19. Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. Kajimoto Y; Kuroiwa T; Miyatake S; Ichioka T; Miyashita M; Tanaka H; Tsuji M J Neurosurg; 2007 Jun; 106(6):1070-4. PubMed ID: 17564181 [TBL] [Abstract][Full Text] [Related]
20. Low field intraoperative MRI-guided surgery of gliomas: a single center experience. Senft C; Franz K; Ulrich CT; Bink A; Szelényi A; Gasser T; Seifert V Clin Neurol Neurosurg; 2010 Apr; 112(3):237-43. PubMed ID: 20036049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]